What Happened?
Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) fell 3.5% in the afternoon session after an analyst at Baird downgraded the stock and cut its price target, citing the potential loss of a major customer. The investment firm lowered its rating on the healthcare products distributor to "Neutral" from "Outperform" and slashed its price target to $72 from $82. The downgrade was prompted by concerns that Heartland Dental, described as Henry Schein's largest global customer, might not renew its contract, which is estimated to be worth around $100 million annually. According to Baird, while the direct financial hit may be manageable, the move could set a precedent for other large customers to seek direct agreements with manufacturers. This possibility creates a potential "overhang" on the stock, which could weigh on its performance in the near to medium term. The negative sentiment was also reflected in the stock's technicals, as shares crossed below their 200-day moving average, a key technical indicator often watched by traders.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Henry Schein? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Henry Schein’s shares are not very volatile and have only had 4 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
Henry Schein is up 3.2% since the beginning of the year, but at $70.76 per share, it is still trading 13.6% below its 52-week high of $81.91 from February 2025. Investors who bought $1,000 worth of Henry Schein’s shares 5 years ago would now be looking at an investment worth $1,185.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.